Literature DB >> 19706597

MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction.

Shimin Dong1, Yunhui Cheng, Jian Yang, Jingyuan Li, Xiaojun Liu, Xiaobin Wang, Dong Wang, Thomas J Krall, Ellise S Delphin, Chunxiang Zhang.   

Abstract

Several recent reports have suggested that microRNAs (miRNAs) might play critical roles in acute myocardial infarction (AMI). However, the miRNA expression signature in the early phase of AMI has not been identified. In this study, the miRNA expression signature was investigated in rat hearts 6 h after AMI. Compared with the expression signature in the noninfarcted areas, 38 miRNAs were differentially expressed in infarcted areas and 33 miRNAs were aberrantly expressed in the border areas. Remarkably, miR-21 expression was significantly down-regulated in infarcted areas, but was up-regulated in border areas. The down-regulation of miR-21 in the infarcted areas was inhibited by ischemic preconditioning, a known cardiac protective method. Overexpression of miR-21 via adenovirus expressing miR-21 (Ad-miR-21) decreased myocardial infarct size by 29% at 24 h and decreased the dimension of left ventricles at 2 weeks after AMI. Using both gain-of-function and loss-of-function approaches in cultured cardiac myocytes, we identified that miR-21 had a protective effect on ischemia-induced cell apoptosis that was associated with its target gene programmed cell death 4 and activator protein 1 pathway. The protective effect of miR-21 against ischemia-induced cardiac myocyte damage was further confirmed in vivo by decreased cell apoptosis in the border and infarcted areas of the infarcted rat hearts after treatment with Ad-miR-21. The results suggest that miRNAs such as miR-21 may play critical roles in the early phase of AMI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706597      PMCID: PMC2785585          DOI: 10.1074/jbc.M109.027896

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

Authors:  Victor Ambros
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Phylogenetic shadowing and computational identification of human microRNA genes.

Authors:  Eugene Berezikov; Victor Guryev; José van de Belt; Erno Wienholds; Ronald H A Plasterk; Edwin Cuppen
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  Modulation of ventricular function through gene transfer in vivo.

Authors:  R J Hajjar; U Schmidt; T Matsui; J L Guerrero; K H Lee; J K Gwathmey; G W Dec; M J Semigran; A Rosenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 5.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

6.  The intervening sequence RNA of Tetrahymena is an enzyme.

Authors:  A J Zaug; T R Cech
Journal:  Science       Date:  1986-01-31       Impact factor: 47.728

7.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans.

Authors:  B Wightman; I Ha; G Ruvkun
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

8.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Inhibition of NOS2 ameliorates cardiac remodeling, improves heart function after myocardial infarction in rats.

Authors:  Bin Zheng; Lin-Sheng Cao; Qiu-Tang Zeng; Xiang Wang; Da-Zhu Li; Yu-Hua Liao
Journal:  Basic Res Cardiol       Date:  2004-04-15       Impact factor: 17.165

10.  MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.

Authors:  Yunhui Cheng; Xiaojun Liu; Shuo Zhang; Ying Lin; Jian Yang; Chunxiang Zhang
Journal:  J Mol Cell Cardiol       Date:  2009-01-27       Impact factor: 5.000

View more
  210 in total

Review 1.  Environmental exposures, epigenetics and cardiovascular disease.

Authors:  Andrea Baccarelli; Sanjukta Ghosh
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

2.  MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation.

Authors:  Jing Zhou; Kuei-Chun Wang; Wei Wu; Shankar Subramaniam; John Y-J Shyy; Jeng-Jiann Chiu; Julie Y-S Li; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

Review 3.  MicroRNA expression and function in cardiac ischemic injury.

Authors:  Shiyong Yu; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2010-06       Impact factor: 4.132

4.  Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.

Authors:  Xiaojun Liu; Yunhui Cheng; Jian Yang; Ling Xu; Chunxiang Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-11-22       Impact factor: 5.000

Review 5.  miRNAs as therapeutic targets in ischemic heart disease.

Authors:  Robert J A Frost; Eva van Rooij
Journal:  J Cardiovasc Transl Res       Date:  2010-03-30       Impact factor: 4.132

Review 6.  microRNAs in cardiovascular development.

Authors:  Jinghai Chen; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2012-01-24       Impact factor: 5.000

7.  Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

Authors:  Michael R Zile; Shannon M Mehurg; Jazmine E Arroyo; Robert E Stroud; Stacia M DeSantis; Francis G Spinale
Journal:  Circ Cardiovasc Genet       Date:  2011-09-28

Review 8.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

9.  Mechanism of programmed cell death factor 4/nuclear factor-κB signaling pathway in porcine coronary micro-embolization-induced cardiac dysfunction.

Authors:  Qiang Su; Lang Li; Jiangyou Wang; You Zhou; Yangchun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

10.  The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.

Authors:  Kamal Razavi-Azarkhiavi; Mahmoud Reza Jaafari; Khalil Abnous; Bibi Marjan Razavi; Amir Hossein Jafarian; Faezeh Vahdati Hassani; Kobra Shirani; Gholamreza Karimi
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.